2022 Q4 Form 10-Q Financial Statement

#000149315222032266 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $1.144M $1.131M $545.4K
YoY Change 68.29% 107.3% 74.4%
Cost Of Revenue $842.5K $873.3K $442.8K
YoY Change 20.41% 97.24% 99.34%
Gross Profit $301.5K $257.2K $102.6K
YoY Change -1615.89% 150.69% 13.26%
Gross Profit Margin 26.36% 22.75% 18.81%
Selling, General & Admin $1.078M $1.075M $756.1K
YoY Change -22.88% 42.18% 51.15%
% of Gross Profit 357.7% 417.94% 736.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $26.38K $25.21K $12.50K
YoY Change 1.66% 101.68% 35.87%
% of Gross Profit 8.75% 9.8% 12.18%
Operating Expenses $1.102M $1.075M $756.1K
YoY Change -22.09% 42.18% 51.15%
Operating Profit -$800.9K -$817.8K -$653.5K
YoY Change -44.18% 25.14% 59.53%
Interest Expense -$199.5K $253.9K $17.15K
YoY Change -76.56% 1380.29% -16.87%
% of Operating Profit
Other Income/Expense, Net -$5.790K -$374.2K
YoY Change -100.3%
Pretax Income -$1.171M -$1.192M -$2.211M
YoY Change -55.37% -46.07% 334.04%
Income Tax -$430.00 $19.52K
% Of Pretax Income
Net Earnings -$1.171M -$1.192M -$2.231M
YoY Change -54.91% -46.56% 337.88%
Net Earnings / Revenue -102.35% -105.44% -409.02%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$677.10 -$2.691K
COMMON SHARES
Basic Shares Outstanding 1.841B shares 1.781B shares 863.5M shares
Diluted Shares Outstanding 1.761B shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.79K $270.8K $546.5K
YoY Change -94.35% -50.45% 2468.28%
Cash & Equivalents $39.79K $270.8K $546.5K
Short-Term Investments
Other Short-Term Assets $45.26K $17.90K $6.517K
YoY Change 49.02% 174.64% -11.45%
Inventory $859.2K $1.008M $866.6K
Prepaid Expenses $62.20K
Receivables $79.53K $56.11K $63.72K
Other Receivables $0.00 $0.00 $14.88K
Total Short-Term Assets $1.024M $1.353M $1.560M
YoY Change -36.16% -13.32% 95.81%
LONG-TERM ASSETS
Property, Plant & Equipment $348.1K $370.5K $281.0K
YoY Change 0.01% 31.84% -65.56%
Goodwill $1.337M $1.276M
YoY Change 0.0%
Intangibles $66.20K $68.64K
YoY Change -12.84%
Long-Term Investments
YoY Change
Other Assets $15.13K $15.13K $2.684M
YoY Change 0.0% -99.44% 41185.6%
Total Long-Term Assets $1.192M $1.278M $2.864M
YoY Change -15.24% -55.37% 220.27%
TOTAL ASSETS
Total Short-Term Assets $1.024M $1.353M $1.560M
Total Long-Term Assets $1.192M $1.278M $2.864M
Total Assets $2.216M $2.631M $4.424M
YoY Change -26.39% -40.54% 161.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.379M $1.041M $206.1K
YoY Change 154.88% 405.05% 85.33%
Accrued Expenses $346.8K $376.8K $183.8K
YoY Change -36.19% 105.03% -89.03%
Deferred Revenue
YoY Change
Short-Term Debt $411.1K $530.6K $2.400M
YoY Change -51.64% -77.89% 380.0%
Long-Term Debt Due $2.498M $2.266M $3.490K
YoY Change 17782.25% 64840.11% -41.83%
Total Short-Term Liabilities $5.295M $5.231M $5.841M
YoY Change 28.22% -10.45% 132.66%
LONG-TERM LIABILITIES
Long-Term Debt $57.06K $71.75K $2.471M
YoY Change -96.32% -97.1% 25.02%
Other Long-Term Liabilities $1.177M
YoY Change 94.18%
Total Long-Term Liabilities $0.00 $0.00 $3.648M
YoY Change -100.0% -100.0% 41.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.295M $5.231M $5.841M
Total Long-Term Liabilities $0.00 $0.00 $3.648M
Total Liabilities $5.981M $5.980M $9.489M
YoY Change -16.17% -36.98% 86.31%
SHAREHOLDERS EQUITY
Retained Earnings -$23.61M -$22.44M -$13.70M
YoY Change 44.86% 63.77%
Common Stock $20.00K $18.07K $8.831K
YoY Change 99.09% 104.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.765M -$3.350M -$5.065M
YoY Change
Total Liabilities & Shareholders Equity $2.216M $2.631M $4.424M
YoY Change -26.39% -40.54% 161.62%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$1.171M -$1.192M -$2.231M
YoY Change -54.91% -46.56% 337.88%
Depreciation, Depletion And Amortization $26.38K $25.21K $12.50K
YoY Change 1.66% 101.68% 35.87%
Cash From Operating Activities -$350.9K -$529.2K -$711.1K
YoY Change -69.32% -25.58% 175.09%
INVESTING ACTIVITIES
Capital Expenditures $1.500K -$18.75K -$119.7K
YoY Change -103.07% -84.33% 418.91%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $2.350K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$1.500K -$18.75K -$117.3K
YoY Change -100.12% -84.02% 408.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 121.4K 812.6K 1.280M
YoY Change 67.49% -36.54% 418.41%
NET CHANGE
Cash From Operating Activities -350.9K -529.2K -711.1K
Cash From Investing Activities -1.500K -18.75K -117.3K
Cash From Financing Activities 121.4K 812.6K 1.280M
Net Change In Cash -231.0K 264.6K 452.0K
YoY Change -246.85% -41.46% -1407.96%
FREE CASH FLOW
Cash From Operating Activities -$350.9K -$529.2K -$711.1K
Capital Expenditures $1.500K -$18.75K -$119.7K
Free Cash Flow -$352.4K -$510.5K -$591.5K
YoY Change -67.81% -13.69% 151.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
usd
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q3 KGKG Financing Cost Expense
FinancingCostExpense
usd
KGKG Financing Cost Expense
FinancingCostExpense
usd
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001802546
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
CY2022Q3 KGKG Financing Cost Expense
FinancingCostExpense
usd
CY2021Q3 KGKG Stock Issued During Period Value Preferred Stock Conversion To Common Stock
StockIssuedDuringPeriodValuePreferredStockConversionToCommonStock
usd
KGKG Stock Issued During Period Value Preferred Stock Conversion To Common Stock
StockIssuedDuringPeriodValuePreferredStockConversionToCommonStock
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
KGKG Losses On Extinguishment Of Debt
LossesOnExtinguishmentOfDebt
usd
KGKG Loss On Change In Fair Value Of Derivative Liabilities
LossOnChangeInFairValueOfDerivativeLiabilities
usd
KGKG Interest Expense Related To Warrants On Convertible Debt
InterestExpenseRelatedToWarrantsOnConvertibleDebt
usd
KGKG Common Stock Issued For Acquisition
CommonStockIssuedForAcquisition
usd
KGKG Increase Decrease In Deposit
IncreaseDecreaseInDeposit
usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
KGKG Payments For Proceeds From In Intellectual Property
PaymentsForProceedsFromInIntellectualProperty
usd
KGKG Repayments Of Long Term Lines Of Credits
RepaymentsOfLongTermLinesOfCredits
usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
KGKG Proceeds From Ppp Notes Payable
ProceedsFromPppNotesPayable
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Stock Issued1
StockIssued1
usd
KGKG Common Shares Issued On Conversion Of Debentures And Accrued Interest
CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest
usd
KGKG Note Payable On Vehicle Purchase
NotePayableOnVehiclePurchase
usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
usd
CY2022Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
KGKG Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
shares
KGKG Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56230
dei Entity Registrant Name
EntityRegistrantName
KONA GOLD BEVERAGE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1915692
dei Entity Address Address Line1
EntityAddressAddressLine1
746 North Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite A
dei Entity Address City Or Town
EntityAddressCityOrTown
Melbourne
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32934
dei City Area Code
CityAreaCode
(844)
dei Local Phone Number
LocalPhoneNumber
714-2224
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1841368987 shares
CY2022Q3 us-gaap Cash
Cash
270793 usd
CY2021Q4 us-gaap Cash
Cash
703825 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
20661 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
11926 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
56105 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15993 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
150000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
150000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1007879 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
574811 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
278707 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
17898 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
30373 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1352675 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1603709 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370518 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
348037 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
823635 usd
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
966955 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
68639 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
75955 usd
CY2022Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
15125 usd
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
15125 usd
CY2022Q3 us-gaap Assets
Assets
2630592 usd
CY2021Q4 us-gaap Assets
Assets
3009781 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1041016 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
541123 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
159583 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
329583 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
479260 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7974 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1787151 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
6000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
663871 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
60000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217166 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
213837 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
530584 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
849933 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
352000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2121000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5230631 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4129450 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1525651 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
71749 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
25338 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
615317 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
677866 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
838883 usd
CY2022Q3 us-gaap Liabilities
Liabilities
5980246 usd
CY2021Q4 us-gaap Liabilities
Liabilities
7134639 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5700250 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5700250 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
988000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
988000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
988000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
988000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
10 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
10 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1806458236 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1806458236 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1004709546 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1004709546 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
18065 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
10047 usd
CY2022Q3 KGKG Common Stock Issuable Shares
CommonStockIssuableShares
170000000 shares
CY2021Q4 KGKG Common Stock Issuable Shares
CommonStockIssuableShares
170000000 shares
CY2022Q3 KGKG Common Stock Issuable
CommonStockIssuable
1386497 usd
CY2021Q4 KGKG Common Stock Issuable
CommonStockIssuable
1386497 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
17688091 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10778761 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22442317 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16300173 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3349654 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4124858 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2630592 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3009781 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1130546 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
545375 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3299075 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1798999 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
873319 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
442766 usd
us-gaap Cost Of Revenue
CostOfRevenue
2608712 usd
us-gaap Cost Of Revenue
CostOfRevenue
1443727 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
257227 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
102609 usd
us-gaap Gross Profit
GrossProfit
690363 usd
us-gaap Gross Profit
GrossProfit
355272 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1075044 usd
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
756110 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3045895 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1968841 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-817817 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-653501 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2355532 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1613569 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
253855 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
817471 usd
us-gaap Interest Expense
InterestExpense
867209 usd
us-gaap Interest Expense
InterestExpense
2013337 usd
KGKG Financing Cost Expense
FinancingCostExpense
260000 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
148000 usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-740220 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1523000 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-864589 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-268810 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1141850 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
95161 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
425 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19523 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5447 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-27065 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-374240 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1577214 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3786612 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2809830 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1192057 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2230715 usd
us-gaap Net Income Loss
NetIncomeLoss
-6142144 usd
us-gaap Net Income Loss
NetIncomeLoss
-4423399 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1760650640 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
829027793 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1580864982 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
863927095 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2991280 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
610683 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
223000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1192057 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3349654 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4124858 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
6469848 usd
KGKG Stock Issued During Period Value Common Stock Issued With Note Payable Received As Debt Discount
StockIssuedDuringPeriodValueCommonStockIssuedWithNotePayableReceivedAsDebtDiscount
135000 usd
KGKG Stock Issued During Period Value Common Stock Issued With Employment Agreement
StockIssuedDuringPeriodValueCommonStockIssuedWithEmploymentAgreement
8500 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
304000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6142144 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3349654 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2603883 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
406652 usd
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55800 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
693555 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2230715 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-3678591 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-2857653 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1529635 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
55800 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
270900 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1746126 usd
us-gaap Net Income Loss
NetIncomeLoss
-4423399 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-3678591 usd
us-gaap Net Income Loss
NetIncomeLoss
-6142144 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
67018 usd
us-gaap Net Income Loss
NetIncomeLoss
-4423399 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
32755 usd
KGKG Right Of Use Asset Adjustments
RightOfUseAssetAdjustments
-143320 usd
KGKG Right Of Use Asset Adjustments
RightOfUseAssetAdjustments
306110 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
702675 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7316 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
35 usd
KGKG Financing Costs
FinancingCosts
260000 usd
KGKG Losses On Extinguishment Of Debt
LossesOnExtinguishmentOfDebt
1141855 usd
KGKG Loss On Change In Fair Value Of Derivative Liabilities
LossOnChangeInFairValueOfDerivativeLiabilities
-1523000 usd
KGKG Interest Expense Related To Warrants On Convertible Debt
InterestExpenseRelatedToWarrantsOnConvertibleDebt
1746126 usd
KGKG Common Stock Issued For Compensation
CommonStockIssuedForCompensation
8500 usd
KGKG Common Stock Issued For Compensation
CommonStockIssuedForCompensation
55800 usd
KGKG Common Stock Issued For Acquisition
CommonStockIssuedForAcquisition
270900 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40147 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
74223 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
433068 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
206109 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-278707 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
62200 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-12475 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
945 usd
KGKG Increase Decrease In Deposit
IncreaseDecreaseInDeposit
6250 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
645765 usd
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
84196 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-170000 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
132083 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
864589 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-153890 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
306110 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2148583 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1586677 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42923 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
145912 usd
KGKG Payments For Proceeds From Goodwill
PaymentsForProceedsFromGoodwill
1275938 usd
KGKG Payments For Proceeds From In Intellectual Property
PaymentsForProceedsFromInIntellectualProperty
5256 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42923 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1427106 usd
KGKG Repayments Of Long Term Lines Of Credits
RepaymentsOfLongTermLinesOfCredits
13000 usd
KGKG Proceeds From Payment Of Acquisition Obligation
ProceedsFromPaymentOfAcquisitionObligation
11446 usd
KGKG Proceeds From Payment Of Acquisition Obligation
ProceedsFromPaymentOfAcquisitionObligation
-590418 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
3798 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
260000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
4500 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
217000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
542000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
34763 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
5598 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
981816 usd
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3029636 usd
KGKG Proceeds From Ppp Notes Payable
ProceedsFromPppNotesPayable
22326 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1758474 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1130546 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
545375 usd
CY2022Q3 KGKG Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1.07 pure
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3447143 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-433032 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
433360 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
703825 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
113168 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
270793 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
546528 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
27065 usd
us-gaap Interest Paid Net
InterestPaidNet
533 usd
us-gaap Interest Paid Net
InterestPaidNet
52091 usd
us-gaap Stock Issued1
StockIssued1
135000 usd
KGKG Common Shares Issued On Conversion Of Debentures And Accrued Interest
CommonSharesIssuedOnConversionOfDebenturesAndAccruedInterest
6469848 usd
KGKG Derivative Liability Recorded On Issuance Of Convertible Note
DerivativeLiabilityRecordedOnIssuanceOfConvertibleNote
680000 usd
KGKG Note Payable On Vehicle Purchase
NotePayableOnVehiclePurchase
46576 usd
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
3 usd
us-gaap Net Income Loss
NetIncomeLoss
-6142144 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2148583 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3349654 usd
CY2022Q3 us-gaap Cash
Cash
270793 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zwqGXKFpwXig" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Those estimates and assumptions include estimates for reserves of uncollectible accounts receivable, assumptions used in valuing inventories at net realizable value, impairment testing of recorded long-term tangible and intangible assets, the valuation allowance for deferred tax assets, accruals for potential liabilities, assumptions made in valuing stock instruments issued for services, and assumptions used in valuing warrant liabilities, and assumptions used in the determination of the Company’s liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
KGKG Sales Percentage
SalesPercentage
0.03 pure
CY2022Q3 KGKG Sales Return And Allowances
SalesReturnAndAllowances
32700 usd
CY2021Q3 KGKG Sales Return And Allowances
SalesReturnAndAllowances
16100 usd
KGKG Sales Return And Allowances
SalesReturnAndAllowances
104500 usd
KGKG Sales Return And Allowances
SalesReturnAndAllowances
43459 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1130546 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
545375 usd
CY2022Q3 KGKG Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
1.07 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3299075 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1798999 usd
KGKG Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
0.83 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3299075 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1798999 usd
KGKG Revenue From Contract With Customer Excluding Assessed Tax Percentage
RevenueFromContractWithCustomerExcludingAssessedTaxPercentage
0.83 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
783159486 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
550800435 shares
us-gaap Advertising Expense
AdvertisingExpense
118807 usd
us-gaap Advertising Expense
AdvertisingExpense
45700 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zf1LQy0TyH7h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Concentrations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s cash balances on deposit with banks are guaranteed by the Federal Deposit Insurance Corporation (FDIC) up to $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20220930_zdxbzgtzVO94" title="Cash FDIC insured amount">250,000</span>. Generally, the Company’s policy is to minimize borrowing costs by immediately applying cash receipts to borrowings against its credit facility. From time to time, however, the Company may be exposed to risk for the amounts of funds held in bank accounts in excess of the FDIC limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Gross sales.</i> During the three months ended September 30, 2022, the Company reported no customers that accounted for more than <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220701__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_z6sYhaKkNuk4" title="Concentration risk percentage">10</span>% of gross sales. During the three months ended September 30, 2021, the Company reported one customer represented <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210701__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_z0lrUIDRRYy6" title="Concentration risk percentage">12</span>% of the Company’s gross sales. During the nine months ended September 30, 2022, the Company reported no customers that accounted for more than <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--NoCustomerMember_zOPdW936Fozf" title="Concentration risk percentage">10</span>% of gross sales. During the nine months ended September 30, 2021, the Company reported one customer represented <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneCustomerMember_zG6ST4Q2QEMj" title="Concentration risk percentage">13</span>% of the Company’s gross sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable.</i> As of September 30, 2022, the Company had six customers that accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--SixCustomersMember_zL2eGAlhYvhk" title="Concentration risk percentage">80</span>% of its gross accounts receivable. As of December 31, 2021, the Company had accounts receivable from two customers that comprised <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--TwoCustomerMember_z8xYrRW5GRVh" title="Concentration risk percentage">60</span>% of its gross accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Co-Packers. </i>The raw materials used in the production of the Company’s products are obtained by the Company’s co-packers and consist primarily of materials such as the flavors, caffeine, sugars or sucralose, taurine, vitamins, CBD, and hemp seed protein contained in its beverages, the bottles in which its beverages are packaged, and the labeling on the outside of its beverages. These principal raw materials are subject to price and availability fluctuations. The Company currently relies on a few key co-packers, which in turn rely on a few key suppliers. The Company continually endeavors to have back-up co-packers, which co-packers would in turn depend on their third-party suppliers to supply certain of the flavors and concentrates that are used in the Company’s beverages. The Company is also dependent on these co-packers to negotiate arrangements with their existing suppliers that would enable the Company to obtain access to certain of such concentrates or flavor formulas under certain extraordinary circumstances. Additionally, in a limited number of cases, the Company’s co-packers may have contractual restrictions with their suppliers or the Company’s co-packers may need to obtain regulatory approvals and licenses that may limit the co-packers’ ability to enter into agreements with alternative suppliers. Contractual restrictions in the agreements the Company has with certain distributors may also limit the Company’s ability to enter into agreements with alternative distributors. The Company believes that a satisfactory supply of co-packers will continue to be available at competitive prices, although there can be no assurance in this regard. The Company continually endeavors to contract with additional beverage vendors to ensure the Company has adequate inventory. The Company believes that a satisfactory supply of vendors will continue to be available at competitive prices, although there can be no assurance in this regard.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Purchases from vendors.</i> During the nine months ended September 30, 2022, the Company’s one vendor accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--OneVendorMember_zmI2ZLlj4oj8" title="Concentration risk, percentage">33</span>% of all purchases, respectively. During the nine months ended September 30, 2021, the Company’s largest three vendors accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorOneMember_zPlp7Ue6Jj98" title="Concentration risk, percentage">17</span>%, <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember_zwY04CvLKs3" title="Concentration risk, percentage">14</span>%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorThreeMember_ziZfhePFcCOk" title="Concentration risk, percentage">11</span>% of all purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable.</i> As of September 30, 2022, two vendors accounted for more than <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--TwoVendorsMember_zCDwk1Wppto6" title="Concentration risk, percentage">49</span>% the total accounts payable. The Company’s largest two vendors accounted for <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zIjTGwpGAb73" title="Concentration risk, percentage">26</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zjPhZYdPPAu4" title="Concentration risk, percentage">23</span>% of the total accounts payable, respectively. As of December 31, 2021, four vendors accounted for more than 10% the total accounts payable. The Company’s largest four vendors accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__srt--MajorCustomersAxis__custom--VendorOneMember_zchG7FU5NkJ8" title="Concentration risk, percentage">20</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zVrir3pEU7E6" title="Concentration risk, percentage">14</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__custom--PurchaseMember__srt--MajorCustomersAxis__custom--VendorThreeMember_zH2dE1PJ6fn9" title="Concentration risk, percentage">12</span>%, and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--VendorFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember_zgtXPKWLCM6h" title="Concentration risk, percentage">11</span>% of the total accounts payable, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
263418 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
70592 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
744461 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
504219 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
1007879 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
574811 usd
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
150000 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
150000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
541657 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
452158 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
171139 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
104121 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370518 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
348037 usd
CY2022Q3 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
85340 usd
CY2021Q4 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
85340 usd
CY2022Q3 KGKG Finite Lived Gross Website Development Trademarks
FiniteLivedGrossWebsiteDevelopmentTrademarks
12200 usd
CY2021Q4 KGKG Finite Lived Gross Website Development Trademarks
FiniteLivedGrossWebsiteDevelopmentTrademarks
12200 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
28901 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
21585 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68639 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
75955 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7316 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2438 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9754 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9754 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9754 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9754 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
27185 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
68639 usd
CY2022Q3 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1787151 usd
CY2021Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
1531651 usd
CY2022Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
1787151 usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
6000 usd
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1525651 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
155281 usd
CY2022Q3 us-gaap Notes Payable
NotesPayable
551009 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
33312 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
479260 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
7974 usd
CY2022Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
71749 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
25338 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
352000 usd
KGKG Derivative Liabilities Activity
DerivativeLiabilitiesActivity
3972000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2121000 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3000000 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2121000 usd
CY2022Q3 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
3972000 usd
CY2022Q3 KGKG Derivative Liabilities Secured Convertible Debentures
DerivativeLiabilitiesSecuredConvertibleDebentures
680000 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
352000 usd
us-gaap Lease Cost
LeaseCost
152841 usd
us-gaap Lease Cost
LeaseCost
93569 usd
CY2021Q4 KGKG Operating Lease Liabilities Right Of Use Asset
OperatingLeaseLiabilitiesRightOfUseAsset
966955 usd
CY2022Q3 KGKG Operating Leases
OperatingLeases
143320 usd
CY2022Q3 KGKG Operating Lease Liabilities Right Of Use Asset
OperatingLeaseLiabilitiesRightOfUseAsset
823635 usd
CY2021Q4 KGKG Lease Liabilities
LeaseLiabilities
1052720 usd
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1027239 usd
KGKG Increase In Operating Lease
IncreaseInOperatingLease
3798 usd
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
153890 usd
CY2022Q3 us-gaap Lease Deposit Liability
LeaseDepositLiability
895032 usd
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
19753 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
875279 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217166 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
677866 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M13D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.1000 pure
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0209 pure
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
77686 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
282347 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
262715 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
261083 usd
CY2022Q3 KGKG Lessee Operating Lease Liability Payments Due Four And After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueFourAndAfterYearFour
198217 usd
CY2022Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1082048 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
187016 usd
CY2022Q3 KGKG Present Value Of Net Minimum Lease Payments
PresentValueOfNetMinimumLeasePayments
895032 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217166 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
677866 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
988000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
988000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2500000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1806458236 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1806458236 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1004709546 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1004709546 shares
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1386497 usd
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1386497 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
170000000 shares
CY2021Q4 KGKG Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.0300
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
108333333 shares
KGKG Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0065
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
278333333 shares
CY2022Q3 KGKG Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
0.0223
CY2022Q3 KGKG Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
278333333 shares
CY2022Q3 KGKG Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercisable Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisablePrice
0.0223
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
278333333 shares
KGKG Class Of Warrant Or Right Number Of Use Ful Life
ClassOfWarrantOrRightNumberOfUseFulLife
P2Y9M10D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
0.03
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
278333333 shares
CY2022Q3 KGKG Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
0.03
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.0060
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
150000 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
100000000 shares
CY2022Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0045
CY2022Q3 KGKG Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.0060
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8333333 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.03
CY2022Q2 KGKG Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.0180

Files In Submission

Name View Source Status
0001493152-22-032266-index-headers.html Edgar Link pending
0001493152-22-032266-index.html Edgar Link pending
0001493152-22-032266.txt Edgar Link pending
0001493152-22-032266-xbrl.zip Edgar Link pending
ex10-51.htm Edgar Link pending
ex10-51_001.jpg Edgar Link pending
ex10-51_002.jpg Edgar Link pending
ex10-51_003.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
kgkg-20220930.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
kgkg-20220930_cal.xml Edgar Link unprocessable
kgkg-20220930_def.xml Edgar Link unprocessable
kgkg-20220930_lab.xml Edgar Link unprocessable
kgkg-20220930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable